Learn more

INTENDIS GMBH

Overview
  • Total Patents
    109
  • GoodIP Patent Rank
    213,407
About

INTENDIS GMBH has a total of 109 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and chemical engineering are LOTUS PHARMACEUTICAL CO LTD, ACROVIS BIOSTRUCTURES GMBH and MELINTA SUBSIDIARY CORP.

Patent filings per year

Chart showing INTENDIS GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Graupe Klaus 20
#2 Franke Patrick 15
#3 Hoffmann Karin 15
#4 Steckel Hartwig 14
#5 Zollner Thomas 13
#6 Schweizer Steffen 13
#7 Schmidt Timm 10
#8 Johannsen Soenke 9
#9 Staedtler Gerald 9
#10 Olbrich Alfred 7

Latest patents

Publication Filing date Title
AU2012261730A1 Anhydrous multiphase gel system
WO2011104385A1 Pharmaceutical product packaging comprising an inspection window
JP2011178464A Rectangular parallelepiped-like secondary packaging means having peephole
DE102010021671A1 Azelaic acid-containing formulation with added pigment
DE102010014429A1 Cuboid-shaped secondary packaging for pharmaceutical blisters- or tubes, has inspection window which allows pharmaceutical products to be visually inspected during dispensing
DE102010009560A1 Cuboid-shaped secondary packaging for pharmaceutical blisters- or tubes, has inspection window which allows pharmaceutical products to be visually inspected during dispensing
EP2201942A1 Compound with hemp oil for the treatment of topical illnesses
EP2201930A1 Hydrogel composition for the treatment of dermatological disorders
EP2210588A1 Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
SG182950A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
NZ615733A Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
EP2016935A1 Pharmaceutical composition for topical application of poorly soluble compounds
EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof
DE102006004804A1 Use of alpha, omega-N-alkanedicarboxylic acid and retinoid for producing rosacea treatment preparation
DE102005037844A1 Anhydrous multi-phase gel system
MY129121A Composition with azelaic acid
CZ20001844A3 Composition containing azelaic acid